Virtus LifeSci Biotech Cl... (BBC)
AMEX: BBC
· Real-Time Price · USD
27.52
0.22 (0.82%)
At close: Oct 01, 2025, 1:41 PM
0.82% (1D)
Bid | 27.5 |
Market Cap | 16.16M |
AUM | 17.44M |
NAV | 26.83 |
EPS (ttm) | n/a |
PE Ratio (ttm) | n/a |
Shares Out | 587.36K |
Inception Date | Dec 16, 2014 |
Ask | 27.68 |
Volume | 8,959 |
Open | 27.80 |
Previous Close | 27.30 |
Day's Range | 27.50 - 27.89 |
52-Week Range | 13.42 - 31.65 |
Holdings | 198 |
Expense Ratio | 0.79% |
About BBC
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Asset Class Equity | Specialty
Ticker Symbol BBC
Inception Date Dec 16, 2014
Provider Virtus Investment Partners
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 16.80% of assets
Name | Symbol | Weight |
---|---|---|
Celcuity Inc. | CELC | 2.68% |
Uniqure N.v. | QURE | 2.40% |
Mineralys Therapeuti... | MLYS | 1.70% |
Rapport Therapeutics... | RAPP | 1.62% |
Tourmaline Bio, Inc. | TRML | 1.56% |
Olema Pharmaceutical... | OLMA | 1.52% |
Stoke Therapeutics, ... | STOK | 1.35% |
Arrowhead Pharmaceut... | ARWR | 1.34% |
Dianthus Therapeutic... | DNTH | 1.32% |
Intellia Therapeutic... | NTLA | 1.31% |
Dividends Dividend Yield 0.98%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Dec 20, 2024 | $0.2395 | Dec 27, 2024 |
Dec 20, 2023 | $0.0823 | Dec 29, 2023 |
Dec 20, 2017 | $0.2972 | Dec 27, 2017 |
Dec 21, 2015 | $0.1470 | Dec 29, 2015 |